Xtant Medical Holdings, Inc. (XTNT) is a publicly traded Healthcare sector company. As of August 4, 2026, XTNT trades at $0.46 with a market cap of $61.72M and a P/E ratio of 11.18. XTNT moved +4.25% today. Year to date, XTNT is -44.41%; over the trailing twelve months it is -21.12%. Its 52-week range spans $0.33 to $0.95. Analyst consensus is buy with an average price target of $1.50. Rallies surfaces XTNT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for XTNT, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $0.46 |
| Market Cap | $61.72M |
| P/E Ratio | 11.18 |
| EPS | $0.04 |
| Dividend Yield | 0.00% |
| 52-Week High | $0.95 |
| 52-Week Low | $0.33 |
| Volume | 44.01K |
| Avg Volume | 0 |
| Revenue (TTM) | $133.93M |
| Net Income | $4.97M |
| Gross Margin | 62.92% |
2 analysts cover XTNT: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $1.50.